INCENP activators represent a diverse chemical class primarily comprised of kinase inhibitors, phosphatase inhibitors, and compounds that modulate second messengers within the cell. These chemicals interact with cellular signaling pathways to indirectly influence the activity of INCENP. By modulating the enzymes that regulate phosphorylation, such as protein phosphatases and kinases, these activators affect the state of INCENP phosphorylation, which is critical for its role in chromosome segregation during mitosis. For instance, okadaic acid and calyculin A, as inhibitors of PP1 and PP2A, can indirectly maintain INCENP in a hyperphosphorylated state, which is associated with its activation.
Moreover, compounds like forskolin, which elevates cAMP levels, can initiate a cascade that leads to the activation of protein kinase A (PKA). PKA can then phosphorylate substrates that may interact with INCENP, impacting its function. Additionally, microtubule-stabilizing agents such as paclitaxel might affect INCENP localization and activation status by altering the dynamics of the mitotic spindle to which INCENP localizes during cell division. While these compounds are not direct activators of INCENP, their influence on cellular signaling and the mitotic machinery implies a role in modulating the activity of INCENP.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A potent inhibitor of protein phosphatase 1 (PP1) and 2A (PP2A), which can increase phosphorylation levels in proteins, potentially enhancing INCENP activity as part of the CPC. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, this compound inhibits PP1 and PP2A, possibly leading to increased phosphorylation and activation of INCENP. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, raising cAMP levels, which may indirectly activate INCENP through PKA-dependent phosphorylation pathways. | ||||||
BI6727 | 755038-65-4 | sc-364432 sc-364432A sc-364432B sc-364432C sc-364432D | 5 mg 50 mg 100 mg 500 mg 1 g | $150.00 $1050.00 $1665.00 $3329.00 $4382.00 | 1 | |
A PLK1 inhibitor that may disrupt normal PLK1 function, potentially altering INCENP localization and function as a feedback mechanism. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Aurora kinase inhibitor that could alter the phosphorylation state of INCENP, indirectly affecting its activity. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
An adenosine kinase inhibitor that may increase the availability of adenosine triphosphate (ATP) and influence INCENP activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which may indirectly affect INCENP activity through stress and apoptosis signaling pathways. | ||||||